BSX - Boston Scientific Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
42.01
+0.32 (+0.77%)
At close: 4:00PM EDT

42.01 0.00 (0.00%)
After hours: 4:49PM EDT

Stock chart is not supported by your current browser
Previous Close41.69
Open41.57
Bid41.76 x 3000
Ask42.30 x 1200
Day's Range41.52 - 42.03
52 Week Range31.56 - 42.40
Volume4,349,510
Avg. Volume8,168,995
Market Cap58.421B
Beta (3Y Monthly)0.66
PE Ratio (TTM)32.82
EPS (TTM)1.28
Earnings DateJul 23, 2019 - Jul 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est43.66
Trade prices are not sourced from all markets
  • Moody's14 minutes ago

    Boston Scientific Corporation -- Moody's announces completion of a periodic review of ratings of Boston Scientific Corporation

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Boston Scientific Corporation and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

  • ACCESSWIRE6 hours ago

    FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BSX, HRTX and BOX

    CEDARHURST, NEW YORK / ACCESSWIRE / June 24, 2019 / The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses. If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.

  • GlobeNewswire6 hours ago

    DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Boston Scientific Corporation (“Boston Scientific” or “the Company”) (NYSE: BSX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

  • ACCESSWIRE7 hours ago

    FINAL DEADLINE ALERT - Boston Scientific Corporation (BSX) Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: June 24, 2019

    NEW YORK, NY / ACCESSWIRE / June 24, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (BSX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Boston Scientific securities between February 26, 2015, and April 16, 2019, both dates inclusive. Boston Scientific was founded in 1979 and is headquartered in Marlborough, Massachusetts. The Company develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

  • ACCESSWIRE3 days ago

    CLASS ACTION UPDATE for BSX, AOS and ASNA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / June 21, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...

  • GlobeNewswire3 days ago

    DEADLINE ALERT - Boston Scientific Corporation (BSX) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: June 24, 2019

    Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Boston Scientific Corporation (“Boston Scientific” or the “Company”) (BSX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Boston Scientific securities between February 26, 2015, and April 16, 2019, both dates inclusive. Boston Scientific was founded in 1979 and is headquartered in Marlborough, Massachusetts.  The Company develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

  • GlobeNewswire3 days ago

    Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation

    Law Offices of Howard G. Smith reminds investors of the upcoming June 24, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Boston Scientific Corporation  (“Boston Scientific” or the “Company”) (NYSE: BSX) securities between February 26, 2015 and April 16, 2019, inclusive (the “Class Period”). Investors suffering losses on their Boston Scientific investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

  • ACCESSWIRE3 days ago

    CLASS ACTION UPDATE for BSX, MOMO and PYX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / June 21, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...

  • ACCESSWIRE3 days ago

    Class Action Upcoming Deadline - S, BSX & INVVY - Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / June 21, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...

  • Near-Term Outlook for Medical Instruments Industry Bleak
    Zacks3 days ago

    Near-Term Outlook for Medical Instruments Industry Bleak

    Near-Term Outlook for Medical Instruments Industry Bleak

  • ACCESSWIRE4 days ago

    CLASS ACTION UPDATE for BSX, CBL and AOS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, NY / ACCESSWIRE / June 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders ...

  • GlobeNewswire4 days ago

    Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Boston Scientific Corporation

    Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 24, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Boston Scientific Corporation  (“Boston Scientific” or the “Company”) (NYSE: BSX) investors who purchased securities between February 26, 2015 and April 16, 2019, inclusive (the “Class Period”).

  • Are Boston Scientific Corporation's (NYSE:BSX) Interest Costs Too High?
    Simply Wall St.4 days ago

    Are Boston Scientific Corporation's (NYSE:BSX) Interest Costs Too High?

    Boston Scientific Corporation (NYSE:BSX), a large-cap worth US$58b, comes to mind for investors seeking a strong and...

  • ACCESSWIRE4 days ago

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, JMIA and BOX

    NEW YORK, NY / ACCESSWIRE / June 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...

  • GlobeNewswire4 days ago

    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprint Corporation, Boston Scientific Corporation, Box, Inc. and Cloudera, Inc. and Encourages Investors to Contact the Firm

    NEW YORK, June 19, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Sprint Corporation,.

  • ACCESSWIRE5 days ago

    S, BSX & INVVY - Class Action Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC

    NEW YORK, NY / ACCESSWIRE / June 19, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...

  • Markit6 days ago

    See what the IHS Markit Score report has to say about Boston Scientific Corp.

    Boston Scientific Corp NYSE:BSXView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for BSX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting BSX. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding BSX are favorable, with net inflows of $9.25 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. BSX credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • ACCESSWIRE7 days ago

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, NOK and MOMO

    NEW YORK, NY / ACCESSWIRE / June 17, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...

  • ACCESSWIRE7 days ago

    S, BSX & INVVY - Bronstein, Gewirtz & Grossman, LLC Class Action Upcoming Deadline

    NEW YORK, NY / ACCESSWIRE / June 17, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...

  • GlobeNewswire7 days ago

    7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

    The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Boston Scientific Corporation (“Boston Scientific” or “the Company”) (NYSE: BSX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

  • GlobeNewswire7 days ago

    CLASS ACTION UPDATE for PSMT, BSX, MBNKF and HL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

    NEW YORK, June 17, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..

  • 3 Stocks To Buy Ahead of Fed Cuts, Says Goldman Sachs
    TipRanks7 days ago

    3 Stocks To Buy Ahead of Fed Cuts, Says Goldman Sachs

    All eyes are on the US Federal Reserve right now. On Wednesday, the Fed will reveal whether it decides to slash interest rates or keep them steady at 2.25% - 2.50%. Ahead of the announcement, the general consensus is that the Fed will keep rates steady but set the groundwork for cuts when it next meets in July. “The markets are set up for a cut in July, and if they don’t get it, financial conditions will tighten” Carl Tannenbaum, chief economist at Northern Trust, told Reuters.So how should investors prepare their portfolios going forward? Goldman Sachs has some advice. “If the Fed does cut rates, the S&P 500 usually rallies afterward, with health care and consumer staples outperforming and information technology consistently lagging,” Goldman's chief U.S. equity strategist David Kostin said. The “communication services sector has generated the best relative returns and hit rate of outperformance during the subsequent 3 months (+4 pp, 100%), but has underperformed over a 12-month horizon.”Here we take a closer look at three stocks that fit into these two categories, with 2 healthcare stocks and 1 consumer staples stock. What’s more, all three of these stocks show a ‘Strong Buy’ Street consensus. That’s based on all ratings received over the last three months. Let’s take a closer look at why analysts are so bullish on these stocks now: 1\. Boston Scientific (BSX)Boston Scientific manufactures medical devices used in interventional medical specialties, including everything from needles to pacemakers. Shares are up 14% year-to-date, and over 80% on a three-year basis. Right now, the company is gearing up for its investor day on June 26. This is the first event since 2017- and expectations are high that BSX met or exceeded all of the 2017 and 2018 financial targets. Needham analyst Mike Matson is confident that BSX can sustain high single digit growth over the next few years, and expects it to target organic revenue growth of 7-9% from 2019 to 2022 at the event. “Given BSX’s strong fundamentals (durable high single digit revenue growth, diversified product portfolio, margin expansion potential, etc.), we believe there is potential for upside to consensus estimates and additional multiple expansion and we reiterate our Strong Buy rating” writes Matson. He reiterated his BSX ‘Buy’ rating on June 14 with a $46 price target (14% upside potential). As we can see here the stock has received 9 recent buy ratings and 1 hold rating:View BSX Price Target & Analyst Ratings Detail 2\. Medtronic (MDT)Ireland-based Medtronic is one of the world’s largest medical device makers. Although the company manufactures a wide range of products, most of the hype right now is centered on the MazorX robotic platform. Medtronic snapped up Mazor Robotics for $1.7 billion late last year, and the two companies have now developed the MazorX Stealth Edition robotic guidance platform. The power of the platform is a preoperative planning suite with 3D analytics and tools, which allows surgeons to optimize the surgical process in advance. “Part of MDT’s revenue acceleration thesis depends on the success of MazorX in driving spine share gains” writes Evercore ISI analyst Vijay Kumar. He recently reiterated his Medtronic Buy rating with a $108 price target. “We think MDT’s view of ‘several hundred bps of share gains’ in spine remains a credible thesis given early trends we are seeing. Extrapolating these to general surgery (~80% systems placed for committed implant / consumable volume) lends further credence to why we think robotic surgery could be a big deal for MDT” writes Kumar. The analyst concludes: “We think MDT is the perfect stock for a choppy environment, and should be a core holding given this revenue reacceleration thesis.” That’s alongside Wells Fargo analyst Larry Biegelsen upgrading Medtronic from Hold to Buy with a $110 price target. The analyst comments "We believe MDT is an accelerating growth story trading at a steep discount to its peers."Overall 7 analysts have published buy ratings on MDT in the last three months, with just 2 analysts staying sidelined.View MDT Price Target & Analyst Ratings Detail 3\. Tyson Foods (TSN)While many investors are pouring money into Beyond Foods, it’s also worth taking a closer look at Tyson Foods. This is the world's second largest processor and marketer of chicken, beef, and pork. However the company has also recently branched out into plant-based meat alternatives, including chicken nuggets and patties. Shares have rocketed with a 53% gain so far year-to-date. Boosting prices further was a rating upgrade from Argus Research’s John Staszak. He has a $92 price target on TSN (12% upside potential).Staszak cited a “growing demand for proteins" and notes that Tyson's beef division is experiencing "especially strong demand". Plus the company is working hard to increase prepared foods sales to satisfy the "steady demand and strong margins." And to top of it, Tyson trades at a multiple of just 12.8-times forward earnings, which is below the average large-cap food processor multiple of 18.4-times. It’s also easily towards the low end of Tyson’s own historical 9- to 19-times range. The stock boasts 7 recent bullish calls, with only 1 analyst publishing a Sell rating (Pivotal Research's Timothy Ramey). View TSN Price Target & Analyst Ratings Detail Discover stock ideas from the Street’s best performing analysts here

  • GlobeNewswire9 days ago

    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Boston Scientific, KushCo, and Nabriva and Encourages Investors to Contact the Firm

    NEW YORK, June 14, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Indivior PLC, Boston.

  • Why This Method Of Replacing A Faulty Heart Valve Is Gaining Steam
    Investor's Business Daily10 days ago

    Why This Method Of Replacing A Faulty Heart Valve Is Gaining Steam

    A nonsurgical method of heart-valve replacement, dubbed TAVR, is gaining steam in the U.S. — propping up medical technology companies Edwards and Medtronic, an analyst said Friday.

  • ACCESSWIRE10 days ago

    The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BSX, ASNA and RMED

    NEW YORK, NY / ACCESSWIRE / June 14, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...